Advanced Medical Solutions Grp PLC Total Voting Rights (6194J)
June 30 2017 - 2:00AM
UK Regulatory
TIDMAMS
RNS Number : 6194J
Advanced Medical Solutions Grp PLC
30 June 2017
30 June 2017
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Total Voting Rights
In accordance with Disclosure and Transparency Rule 5.6.1, the
issued share capital of Advanced Medical Solutions Group plc as at
30 June 2017 comprises 212,118,648 ordinary shares of 5p each with
voting rights. There are no shares held in treasury.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest
in, the Company under the FCA's Disclosure and Transparency
Rules.
- Ends -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Chief Financial
Officer
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Jonathan AMS@consilium-comms.com
Birt / Matthew Neal / Hendrik
Thys
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Daniel Adams / Patrick Robb
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical and wound care markets, focused on quality outcomes for
patients and value for payors. AMS has a wide range of wound care
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it sells under white label
as well as its own brand ActivHeal(R) , and surgical tissue
adhesives, sutures and haemostats, which markets under its own
brands; LiquiBand(R) and RESORBA(R) .
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in more than 75 countries via a network of multinational or
regional partners and distributors, as well as via AMS's own direct
sales forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Company has 600 employees. For more
information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVREADKNAFXXEFF
(END) Dow Jones Newswires
June 30, 2017 02:00 ET (06:00 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024